_version_ 1783749454068711424
author Mantoan, Barbara
Genuardi, Elisa
Ferrante, Martina
Della Starza, Irene
Ciabatti, Elena
Grassi, Susanna
De Novi, Lucia Anna
Cavalli, Marzia
Mannu, Claudia
Gazzola, Anna
Bomben, Riccardo
Degan, Massimo
Alessandria, Beatrice
Pott, Christiane
Delfau-Larue, Marie-Hélène
García-Sanz, Ramon
Agostinelli, Claudio
Gattei, Valter
Galimberti, Sara
Del Giudice, Ilaria
Gaidano, Gianluca
Ladetto, Marco
Ferrero, Simone
Drandi, Daniela
author_facet Mantoan, Barbara
Genuardi, Elisa
Ferrante, Martina
Della Starza, Irene
Ciabatti, Elena
Grassi, Susanna
De Novi, Lucia Anna
Cavalli, Marzia
Mannu, Claudia
Gazzola, Anna
Bomben, Riccardo
Degan, Massimo
Alessandria, Beatrice
Pott, Christiane
Delfau-Larue, Marie-Hélène
García-Sanz, Ramon
Agostinelli, Claudio
Gattei, Valter
Galimberti, Sara
Del Giudice, Ilaria
Gaidano, Gianluca
Ladetto, Marco
Ferrero, Simone
Drandi, Daniela
author_sort Mantoan, Barbara
collection PubMed
description
format Online
Article
Text
id pubmed-8423385
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-84233852021-09-09 Quality Assessment for PCR-based Minimal Residual Disease in Lymphoma: 10 Years of Cross-laboratory Standardization Process Within the Fondazione Italiana Linfomi MRD Network Mantoan, Barbara Genuardi, Elisa Ferrante, Martina Della Starza, Irene Ciabatti, Elena Grassi, Susanna De Novi, Lucia Anna Cavalli, Marzia Mannu, Claudia Gazzola, Anna Bomben, Riccardo Degan, Massimo Alessandria, Beatrice Pott, Christiane Delfau-Larue, Marie-Hélène García-Sanz, Ramon Agostinelli, Claudio Gattei, Valter Galimberti, Sara Del Giudice, Ilaria Gaidano, Gianluca Ladetto, Marco Ferrero, Simone Drandi, Daniela Hemasphere Letter Lippincott Williams & Wilkins 2021-09-06 /pmc/articles/PMC8423385/ /pubmed/34514343 http://dx.doi.org/10.1097/HS9.0000000000000639 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter
Mantoan, Barbara
Genuardi, Elisa
Ferrante, Martina
Della Starza, Irene
Ciabatti, Elena
Grassi, Susanna
De Novi, Lucia Anna
Cavalli, Marzia
Mannu, Claudia
Gazzola, Anna
Bomben, Riccardo
Degan, Massimo
Alessandria, Beatrice
Pott, Christiane
Delfau-Larue, Marie-Hélène
García-Sanz, Ramon
Agostinelli, Claudio
Gattei, Valter
Galimberti, Sara
Del Giudice, Ilaria
Gaidano, Gianluca
Ladetto, Marco
Ferrero, Simone
Drandi, Daniela
Quality Assessment for PCR-based Minimal Residual Disease in Lymphoma: 10 Years of Cross-laboratory Standardization Process Within the Fondazione Italiana Linfomi MRD Network
title Quality Assessment for PCR-based Minimal Residual Disease in Lymphoma: 10 Years of Cross-laboratory Standardization Process Within the Fondazione Italiana Linfomi MRD Network
title_full Quality Assessment for PCR-based Minimal Residual Disease in Lymphoma: 10 Years of Cross-laboratory Standardization Process Within the Fondazione Italiana Linfomi MRD Network
title_fullStr Quality Assessment for PCR-based Minimal Residual Disease in Lymphoma: 10 Years of Cross-laboratory Standardization Process Within the Fondazione Italiana Linfomi MRD Network
title_full_unstemmed Quality Assessment for PCR-based Minimal Residual Disease in Lymphoma: 10 Years of Cross-laboratory Standardization Process Within the Fondazione Italiana Linfomi MRD Network
title_short Quality Assessment for PCR-based Minimal Residual Disease in Lymphoma: 10 Years of Cross-laboratory Standardization Process Within the Fondazione Italiana Linfomi MRD Network
title_sort quality assessment for pcr-based minimal residual disease in lymphoma: 10 years of cross-laboratory standardization process within the fondazione italiana linfomi mrd network
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423385/
https://www.ncbi.nlm.nih.gov/pubmed/34514343
http://dx.doi.org/10.1097/HS9.0000000000000639
work_keys_str_mv AT mantoanbarbara qualityassessmentforpcrbasedminimalresidualdiseaseinlymphoma10yearsofcrosslaboratorystandardizationprocesswithinthefondazioneitalianalinfomimrdnetwork
AT genuardielisa qualityassessmentforpcrbasedminimalresidualdiseaseinlymphoma10yearsofcrosslaboratorystandardizationprocesswithinthefondazioneitalianalinfomimrdnetwork
AT ferrantemartina qualityassessmentforpcrbasedminimalresidualdiseaseinlymphoma10yearsofcrosslaboratorystandardizationprocesswithinthefondazioneitalianalinfomimrdnetwork
AT dellastarzairene qualityassessmentforpcrbasedminimalresidualdiseaseinlymphoma10yearsofcrosslaboratorystandardizationprocesswithinthefondazioneitalianalinfomimrdnetwork
AT ciabattielena qualityassessmentforpcrbasedminimalresidualdiseaseinlymphoma10yearsofcrosslaboratorystandardizationprocesswithinthefondazioneitalianalinfomimrdnetwork
AT grassisusanna qualityassessmentforpcrbasedminimalresidualdiseaseinlymphoma10yearsofcrosslaboratorystandardizationprocesswithinthefondazioneitalianalinfomimrdnetwork
AT denoviluciaanna qualityassessmentforpcrbasedminimalresidualdiseaseinlymphoma10yearsofcrosslaboratorystandardizationprocesswithinthefondazioneitalianalinfomimrdnetwork
AT cavallimarzia qualityassessmentforpcrbasedminimalresidualdiseaseinlymphoma10yearsofcrosslaboratorystandardizationprocesswithinthefondazioneitalianalinfomimrdnetwork
AT mannuclaudia qualityassessmentforpcrbasedminimalresidualdiseaseinlymphoma10yearsofcrosslaboratorystandardizationprocesswithinthefondazioneitalianalinfomimrdnetwork
AT gazzolaanna qualityassessmentforpcrbasedminimalresidualdiseaseinlymphoma10yearsofcrosslaboratorystandardizationprocesswithinthefondazioneitalianalinfomimrdnetwork
AT bombenriccardo qualityassessmentforpcrbasedminimalresidualdiseaseinlymphoma10yearsofcrosslaboratorystandardizationprocesswithinthefondazioneitalianalinfomimrdnetwork
AT deganmassimo qualityassessmentforpcrbasedminimalresidualdiseaseinlymphoma10yearsofcrosslaboratorystandardizationprocesswithinthefondazioneitalianalinfomimrdnetwork
AT alessandriabeatrice qualityassessmentforpcrbasedminimalresidualdiseaseinlymphoma10yearsofcrosslaboratorystandardizationprocesswithinthefondazioneitalianalinfomimrdnetwork
AT pottchristiane qualityassessmentforpcrbasedminimalresidualdiseaseinlymphoma10yearsofcrosslaboratorystandardizationprocesswithinthefondazioneitalianalinfomimrdnetwork
AT delfaularuemariehelene qualityassessmentforpcrbasedminimalresidualdiseaseinlymphoma10yearsofcrosslaboratorystandardizationprocesswithinthefondazioneitalianalinfomimrdnetwork
AT garciasanzramon qualityassessmentforpcrbasedminimalresidualdiseaseinlymphoma10yearsofcrosslaboratorystandardizationprocesswithinthefondazioneitalianalinfomimrdnetwork
AT agostinelliclaudio qualityassessmentforpcrbasedminimalresidualdiseaseinlymphoma10yearsofcrosslaboratorystandardizationprocesswithinthefondazioneitalianalinfomimrdnetwork
AT gatteivalter qualityassessmentforpcrbasedminimalresidualdiseaseinlymphoma10yearsofcrosslaboratorystandardizationprocesswithinthefondazioneitalianalinfomimrdnetwork
AT galimbertisara qualityassessmentforpcrbasedminimalresidualdiseaseinlymphoma10yearsofcrosslaboratorystandardizationprocesswithinthefondazioneitalianalinfomimrdnetwork
AT delgiudiceilaria qualityassessmentforpcrbasedminimalresidualdiseaseinlymphoma10yearsofcrosslaboratorystandardizationprocesswithinthefondazioneitalianalinfomimrdnetwork
AT gaidanogianluca qualityassessmentforpcrbasedminimalresidualdiseaseinlymphoma10yearsofcrosslaboratorystandardizationprocesswithinthefondazioneitalianalinfomimrdnetwork
AT ladettomarco qualityassessmentforpcrbasedminimalresidualdiseaseinlymphoma10yearsofcrosslaboratorystandardizationprocesswithinthefondazioneitalianalinfomimrdnetwork
AT ferrerosimone qualityassessmentforpcrbasedminimalresidualdiseaseinlymphoma10yearsofcrosslaboratorystandardizationprocesswithinthefondazioneitalianalinfomimrdnetwork
AT drandidaniela qualityassessmentforpcrbasedminimalresidualdiseaseinlymphoma10yearsofcrosslaboratorystandardizationprocesswithinthefondazioneitalianalinfomimrdnetwork